Index Performance
+3.14%
SYNB
Overview
Description
SynBio market (incl. biomedical, bioservices & bioprocess, food & agriculture, industrial bioproducts & ingredients, biotools & reagents) is booming.
- TickerSYNB
- Inception Date01/13/2023
- WeightingMarket Cap
- # of holdings96
What's inside?
Holdings
All holdings as of May 2, 2024
CSV download
| Moderna, Inc. (MRNA) | 24.78% | $48.09B | -91.07% | 42.51% | 6.49 |
| BioNTech SE (BNTX) | 11.67% | $21.93B | -77.31% | 85.01% | 3.14 |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 9.77% | $19.01B | 54.82% | 86.65% | N/A |
| BioMarin Pharmaceutical, Inc. (BMRN) | 8.25% | $15.91B | 9.34% | 78.49% | 7.05 |
| Sarepta Therapeutics, Inc. (SRPT) | 6.39% | $12.35B | 63.10% | 85.66% | 9.14 |
| Ionis Pharmaceuticals, Inc. (IONS) | 3.23% | $6.28B | 34.10% | 95.98% | 8.73 |
| ImmunityBio, Inc. (IBRX) | 2.97% | $6.07B | 159.17% | -2,876.21% | 5,099.06 |
| BridgeBio Pharma, Inc. (BBIO) | 2.63% | $5.19B | 11,461.88% | N/A | N/A |
| CRISPR Therapeutics AG (CRSP) | 2.37% | $4.67B | 30,885.48% | 59.57% | 9.44 |
| Iovance Biotherapeutics, Inc. (IOVA) | 1.91% | $3.60B | N/A | -2,686.12% | 1,436.18 |
| Ultragenyx Pharmaceutical, Inc. (RARE) | 1.82% | $3.56B | 19.52% | 84.48% | 8.92 |
| Genscript Biotech Corp. (1548) | 1.68% | $3.34B | 34.15% | 48.78% | 5.32 |
| Amicus Therapeutics, Inc. (FOLD) | 1.61% | $3.09B | 21.30% | 88.68% | 10.89 |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 1.50% | $2.99B | -94.32% | -20.05% | 19.11 |
| 10X Genomics, Inc. (TXG) | 1.47% | $2.78B | 5.01% | 67.78% | 6.72 |
| Arcellx, Inc. (ACLX) | 1.44% | $2.84B | N/A | 98.15% | 18.68 |
| PTC Therapeutics, Inc. (PTCT) | 1.31% | $2.58B | -4.66% | 68.46% | 1.90 |
| Sana Biotechnology, Inc. (SANA) | 1.14% | $2.16B | N/A | N/A | N/A |
| Intellia Therapeutics, Inc. (NTLA) | 1.13% | $2.24B | -30.40% | 75.26% | 52.65 |
| Avidity Biosciences, Inc. (RNA) | 1.04% | $2.04B | 3.64% | 78.02% | 7.87 |
| Twist Bioscience Corp. (TWST) | 0.99% | $1.85B | 31.81% | 40.51% | 7.24 |
| Beam Therapeutics, Inc. (BEAM) | 0.94% | $1.86B | 520.01% | 94.70% | 2.87 |
| Ginkgo Bioworks Holdings, Inc. (DNA) | 0.72% | $1.46B | -47.36% | 56.73% | 10.26 |
| 4D Molecular Therapeutics, Inc. (FDMT) | 0.63% | $1.35B | 562.29% | 72.26% | 25.06 |
| Oxford Nanopore Technologies Plc (ONT) | 0.59% | $1.15B | -14.57% | 42.43% | 8.89 |
| Maravai Lifesciences Holdings, Inc. (MRVI) | 0.57% | $1.16B | -67.28% | 47.62% | 4.41 |
| CanSino Biologics, Inc. (CASBF) | 0.54% | $834.12M | 8.16% | 58.84% | 4.68 |
| REGENXBIO, Inc. (RGNX) | 0.42% | $815.24M | -19.94% | 39.57% | 6.64 |
| Wave Life Sciences Ltd. (WVE) | 0.37% | $719.23M | 3,005.10% | 91.88% | 3.31 |
| Arcturus Therapeutics Holdings, Inc. (ARCT) | 0.37% | $714.13M | -23.42% | 98.13% | 3.31 |
| CureVac NV (CVAC) | 0.32% | $620.16M | -17.98% | -172.97% | 9.14 |
| Absci Corp. (ABSI) | 0.28% | $563.15M | -0.50% | -144.82% | 50.48 |
| Allogene Therapeutics, Inc. (ALLO) | 0.25% | $507.05M | -39.10% | N/A | N/A |
| Arbutus Biopharma Corp. (ABUS) | 0.25% | $482.87M | -77.09% | N/A | N/A |
| Verve Therapeutics, Inc. (VERV) | 0.25% | $483.08M | 505.77% | 53.61% | 29.39 |
| Editas Medicine, Inc. (EDIT) | 0.24% | $462.16M | 296.32% | 92.24% | 6.18 |
| Voyager Therapeutics, Inc. (VYGR) | 0.24% | $463.18M | 511.16% | 98.22% | 0.66 |
| Carbios SA (ALCRB) | 0.23% | $432.69M | -65.71% | N/A | 10,249.20 |
| Entrada Therapeutics, Inc. (TRDA) | 0.23% | $456.67M | N/A | 97.80% | 1.67 |
| PepGen Inc. (PEPG) | 0.22% | $469.32M | N/A | N/A | N/A |
| Fate Therapeutics, Inc. (FATE) | 0.20% | $466.65M | -34.03% | 71.22% | 2.46 |
| Oxford Biomedica Plc (OXB) | 0.20% | $375.55M | -36.04% | 43.78% | 2.50 |
| Solid Biosciences, Inc. (SLDB) | 0.19% | $386.25M | -100.00% | N/A | N/A |
| Precigen, Inc. (PGEN) | 0.18% | $353.39M | -76.87% | -76.18% | 43.68 |
| Caribou Biosciences, Inc. (CRBU) | 0.17% | $328.76M | 148.91% | 89.78% | 3.53 |
| MeiraGTx Holdings Plc (MGTX) | 0.15% | $320.89M | -11.95% | 2.05% | 25.41 |
| Calyxt, Inc. (CLXT) | 0.14% | $355.56M | 1,057.32% | N/A | 131.71 |
| Poseida Therapeutics, Inc. (PSTX) | 0.14% | $270.43M | -50.42% | 91.32% | 2.72 |
| 2seventy Bio, Inc. (TSVT) | 0.13% | $253.43M | 9.72% | 72.90% | 2.49 |
| Codexis, Inc. (CDXS) | 0.12% | $235.66M | -49.39% | 73.87% | 2.35 |
| Adverum Biotechnologies, Inc. (ADVM) | 0.11% | $207.55M | N/A | -56.78% | 15.11 |
| uniQure NV (QURE) | 0.11% | $227.16M | -85.12% | -61.13% | 14.99 |
| Graphite Bio, Inc. (GRPH) | 0.11% | $135.99M | N/A | N/A | N/A |
| Cellectis SA (ALCLS) | 0.10% | $199.70M | -96.17% | -2,446.23% | 81.81 |
| Generation Bio Co. (GBIO) | 0.10% | $206.78M | N/A | 10.86% | -10.17 |
| bluebird bio, Inc. (BLUE) | 0.08% | $174.10M | 720.13% | N/A | N/A |
| Capricor Therapeutics, Inc. (CAPR) | 0.08% | $165.08M | 886.81% | 95.75% | 3.86 |
| Aemetis, Inc. (AMTX) | 0.08% | $166.28M | -27.21% | 1.08% | 3.29 |
| Gevo, Inc. (GEVO) | 0.08% | $159.77M | 1,363.83% | -103.71% | -1.66 |
| ProQR Therapeutics NV (PRQR) | 0.08% | $160.83M | 65.99% | N/A | 7.22 |
| Adicet Bio, Inc. (ACET) | 0.06% | $115.86M | -100.00% | N/A | N/A |
| Vor Biopharma, Inc. (VOR) | 0.06% | $120.06M | N/A | N/A | N/A |
| Agronomics Ltd. (AGNMF) | 0.05% | $104.88M | -100.00% | N/A | N/A |
| Abeona Therapeutics, Inc. (ABEO) | 0.05% | $111.34M | 147.52% | 8.63% | 17.13 |
| Kraig Biocraft Laboratories, Inc. (KBLB) | 0.05% | $93.45M | N/A | N/A | N/A |
| Sangamo Therapeutics, Inc. (SGMO) | 0.05% | $106.31M | 58.34% | 87.41% | 0.29 |
| Atara Biotherapeutics, Inc. (ATRA) | 0.04% | $77.62M | -86.51% | -3.65% | 7.04 |
| Precision BioSciences, Inc. (DTIL) | 0.04% | $74.97M | 94.15% | 83.06% | -0.89 |
| Vascular Biogenics Ltd. (VBLT) | 0.03% | $66.98M | -100.00% | N/A | -12.96 |
| Regulus Therapeutics, Inc. (RGLS) | 0.03% | $176.10M | N/A | N/A | N/A |
| Passage Bio, Inc. (PASG) | 0.03% | $82.56M | N/A | N/A | N/A |
| Avrobio, Inc. (AVRO) | 0.03% | $55.18M | N/A | N/A | N/A |
| Percheron Therapeutics Ltd. (ATHJF) | 0.02% | $45.38M | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI) | 0.02% | $43.86M | -1.07% | 31.84% | 13.54 |
| MediGene AG (MDG1) | 0.02% | $48.91M | -80.69% | 49.40% | 3.93 |
| Evogene Ltd. (EVGN) | 0.02% | $35.69M | 269.59% | 24.80% | N/A |
| Gensight Biologics SA (GSGTF) | 0.02% | $33.10M | -50.93% | N/A | 30.40 |
| Benitec Biopharma, Inc. (BNTC) | 0.01% | $22.99M | -100.00% | N/A | -190.88 |
| Alaunos Therapeutics, Inc. (TCRT) | 0.01% | $21.78M | -99.83% | -46,200.00% | 2,180.19 |
| Senti Biosciences, Inc. (SNTI) | 0.01% | $16.87M | -40.25% | -104.76% | 12.11 |
| Celyad Oncology SA (CYAD) | 0.01% | $13.75M | N/A | 871.57% | 203.10 |
| BacTech Environmental Corp. (BAC) | <0.01% | $8.78M | N/A | N/A | N/A |
| Willow Biosciences, Inc. (CANSF) | <0.01% | $9.07M | 42.75% | -56.23% | 9.74 |
| Evolva Holding SA (EVE) | <0.01% | $7.74M | 57.32% | N/A | 6.29 |
| AquaBounty Technologies, Inc. (AQB) | <0.01% | $7.61M | -21.18% | -605.31% | 4.67 |
| Sorrento Therapeutics, Inc. (SRNE) | <0.01% | $7.72M | 31.10% | 36.24% | 5.16 |
| Cult Food Science Corp. (CULT) | <0.01% | $3.87M | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO) | <0.01% | $3.08M | N/A | N/A | N/A |
| Yield10 Bioscience, Inc. (YTEN) | <0.01% | $3.53M | -86.67% | -383.33% | 66.86 |
| Arcadia Biosciences, Inc. (RKDA) | <0.01% | $2.71M | -46.46% | 38.09% | -1.29 |
| Bio-Path Holdings, Inc. (BPTH) | <0.01% | $4.16M | N/A | N/A | N/A |
| Phio Pharmaceuticals Corp. (PHIO) | <0.01% | $3.56M | N/A | N/A | N/A |
| NeuBase Therapeutics, Inc. (NBSE) | <0.01% | $1.55M | N/A | N/A | N/A |
| Eat & Beyond Global Holdings, Inc. (EATS) | <0.01% | $1.11M | N/A | N/A | -104.42 |
| Amyris, Inc. (AMRS) | <0.01% | $0.74M | -21.06% | N/A | 5.40 |
| SeqLL, Inc. (SQL) | <0.01% | $0.49M | -100.00% | N/A | N/A |
Market data by FactSet
